Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jagadeesh Bayry

Showing results (21-30 of 224) with videos related to

Pageof 23
Sort By:
Oncoimmunology|September 14, 2020
Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanismsMrinmoy Das, Emmanuel Stephen-Victor, Jagadeesh Bayry
Clinical & Translational Immunology|October 22, 2020
Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19)Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Trends in Molecular Medicine|February 15, 2015
Molecular and immunological biomarkers to predict IVIg responseCaroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Future Microbiology|July 28, 2022
Role of the PD-1 and PD-L1 axis in COVID-19Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry
Journal of the Indian Institute of Science|August 15, 2022
COVID-19: A Veterinary and One Health PerspectiveDeepak Kumar, Jagadeesh Bayry, Nagendra R Hegde
Clinical Reviews in Allergy & Immunology|November 12, 2025
COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG TherapySukanya Bordoloi, Suraj C Singh, Jagadeesh Bayry
Cell Reports. Medicine|July 19, 2023
Obesity negatively impacts maintenance of antibody response to COVID-19 vaccinesCamille Chauvin, Sruthi Vijaya Retnakumar, Jagadeesh Bayry
Autoimmunity Reviews|March 8, 2011
Comparison of different IVIg preparations on IL-17 production by human Th17 cellsMohan S Maddur, Srini V Kaveri, Jagadeesh Bayry
Frontiers in Immunology|January 26, 2023
Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cellsSrinivasa Reddy Bonam, Peter Paul Platenburg, Jagadeesh Bayry
Trends in Pharmacological Sciences|May 25, 2015
IVIg for relapsing-remitting multiple sclerosis: promises and uncertaintiesJagadeesh Bayry, Hans-Peter Hartung, Srini V Kaveri
Pageof 23

Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Oncoimmunology|September 14, 2020
Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanismsMrinmoy Das, Emmanuel Stephen-Victor, Jagadeesh Bayry
Clinical & Translational Immunology|October 22, 2020
Intravenous immunoglobulin immunotherapy for coronavirus disease-19 (COVID-19)Caroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Trends in Molecular Medicine|February 15, 2015
Molecular and immunological biomarkers to predict IVIg responseCaroline Galeotti, Srini V Kaveri, Jagadeesh Bayry
Future Microbiology|July 28, 2022
Role of the PD-1 and PD-L1 axis in COVID-19Srinivasa R Bonam, Haitao Hu, Jagadeesh Bayry
Journal of the Indian Institute of Science|August 15, 2022
COVID-19: A Veterinary and One Health PerspectiveDeepak Kumar, Jagadeesh Bayry, Nagendra R Hegde
Clinical Reviews in Allergy & Immunology|November 12, 2025
COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG TherapySukanya Bordoloi, Suraj C Singh, Jagadeesh Bayry
Cell Reports. Medicine|July 19, 2023
Obesity negatively impacts maintenance of antibody response to COVID-19 vaccinesCamille Chauvin, Sruthi Vijaya Retnakumar, Jagadeesh Bayry
Autoimmunity Reviews|March 8, 2011
Comparison of different IVIg preparations on IL-17 production by human Th17 cellsMohan S Maddur, Srini V Kaveri, Jagadeesh Bayry
Frontiers in Immunology|January 26, 2023
Retrospective analysis on the immunopotentiating mechanism of an emulsion-based vaccine adjuvant on human antigen presenting cellsSrinivasa Reddy Bonam, Peter Paul Platenburg, Jagadeesh Bayry
Trends in Pharmacological Sciences|May 25, 2015
IVIg for relapsing-remitting multiple sclerosis: promises and uncertaintiesJagadeesh Bayry, Hans-Peter Hartung, Srini V Kaveri
Pageof 23